Get Breaking Health News headlines emailed to you daily.
Inhibitex Successfully Completes Phase 1a Trial Of INX-189 Source: Medical News Today Friday 3rd September, 2010
Inhibitex, Inc. (Nasdaq: INHX), announced that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the... ...
